Answers are grounded in this paper and cite their sources.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Magierska A, Ptak O, Szczepaniak Z, Gomułka K. Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(5):998-1000. doi:10.5114/ada.2022.120893. APA Magierska, A., Ptak, O., Szczepaniak, Z., & Gomułka, K. (2022). Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(5), 998-1000. https://doi.org/10.5114/ada.2022.120893 Chicago Magierska, Agata, Olga Ptak, Zuzanna Szczepaniak, and Krzysztof Gomułka. 2022. "Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 39 (5): 998-1000. doi:10.5114/ada.2022.120893. Harvard Magierska, A., Ptak, O., Szczepaniak, Z., and Gomułka, K. (2022). Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(5), pp.998-1000. https://doi.org/10.5114/ada.2022.120893 MLA Magierska, Agata et al. "Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 39, no. 5, 2022, pp. 998-1000. doi:10.5114/ada.2022.120893. Vancouver Magierska A, Ptak O, Szczepaniak Z, Gomułka K. Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(5):998-1000. doi:10.5114/ada.2022.120893.
No takes yet. Share an insight, caveat, or question.
Magierska et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: